earnings
confidence high
sentiment positive
materiality 0.75
Veracyte Q1 2026 revenue $139.1M (+21% YoY); GAAP net income $28.7M, adj. EBITDA $42.8M
VERACYTE, INC.
2026-Q1 EPS reported
$0.35
revenue$139,071,000
- Total revenue $139.1M (+21% YoY); testing revenue $135.1M (+26% YoY).
- GAAP net income $28.7M (20.6% of revenue); adjusted EBITDA $42.8M (30.8% of revenue).
- Decipher revenue $86.5M (+30%); Afirma revenue $46.4M (+21%).
- Testing volume 45,248 (+19%); Decipher tests ~28,000 (+24%), Afirma ~17,200 (+12%).
- Cash from operations $35.2M; cash & investments $439.1M; added Haas as CDTO and Ward as CHRO.